Back to Search
Start Over
Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry
- Source :
- Canadian Journal of Cardiology, 35(2), 199-207. Elsevier Inc.
- Publication Year :
- 2018
-
Abstract
- Background Several clinical and procedural factors determine outcomes after transcatheter aortic valve replacement (TAVR), but data are scarce on the impact of post-TAVR discharge disposition on long-term outcomes. We sought to analyse whether discharge location after TAVR is associated with 1-year outcomes in women undergoing contemporary TAVR. Methods The Women’s INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry is the first all-female TAVR registry to study the safety and performance of contemporary TAVR in women (n = 1019). Information on discharge location was available in 817 patients (80.2%). We compared women discharged home vs those discharged to another location (nursing home, rehabilitation, or other hospital). One-year outcomes were adjusted using multivariable Cox regression methods with discharge home as the reference group. Results Of the study subjects, 75.2% (n = 614) were discharged home and 24.8% (n = 203) to another location. Women discharged to other locations were older with a greater prevalence of severe lung disease requiring home oxygen and renal failure on dialysis but were less frequently considered frail or at high surgical risk compared with women discharged home. After multivariable adjustment, non-home discharge was associated with greater hazard for 1-year Valve Academic Research Consortium 2 efficacy (21.3% vs 10.8%, hazards ratio [HR] 1.9, 95% confidence interval [CI] 1.2-2.9) and safety endpoints (31.5% vs 15.2%, HR 2.1, 95% CI 1.5-3.0), cardiovascular death (12.7% vs 5.5%, HR 2.0, 95% CI 1.1-3.6), and stroke (6.5% vs 0.8%, HR 8.5, 95% CI 2.9-25.6). Conclusions In women undergoing contemporary TAVR, discharge disposition significantly affects 1-year risk of outcomes even after adjustment for recorded baseline differences. This might suggest the necessity of considering additional factors beyond comorbidities in the TAVR decision-making process.
- Subjects :
- medicine.medical_specialty
Time Factors
medicine.medical_treatment
030204 cardiovascular system & hematology
Risk Assessment
Transcatheter Aortic Valve Replacement
03 medical and health sciences
0302 clinical medicine
Postoperative Complications
Valve replacement
Risk Factors
medicine
Humans
030212 general & internal medicine
Prospective Studies
Registries
Prospective cohort study
Stroke
Dialysis
Aged, 80 and over
business.industry
Proportional hazards model
Incidence (epidemiology)
Incidence
Hazard ratio
Aortic Valve Stenosis
medicine.disease
Confidence interval
Patient Discharge
Europe
Treatment Outcome
Aortic Valve
Heart Valve Prosthesis
Emergency medicine
North America
Female
Cardiology and Cardiovascular Medicine
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 19167075 and 0828282X
- Volume :
- 35
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- The Canadian journal of cardiology
- Accession number :
- edsair.doi.dedup.....acd1e7a46149d4bc27940e25149f3d4d